Hormone Therapy During Menopause Does Not Increase Mortality, Study Finds
Recent research indicates that hormone therapy (HT) used to manage menopause symptoms does not increase a woman’s risk of death, challenging long-held concerns about its safety. The findings, reported by multiple news outlets, offer reassurance to women and healthcare providers regarding the use of HT for symptom relief.
For years, questions have lingered about a potential link between hormone therapy and increased mortality. This new body of evidence suggests those fears may be unfounded. Several reports detail how the research has, “finally cleared hormone treatments of the risk of increased mortality,” and that hormone therapy “does not increase the risk of death.”
The studies analyzed data to assess the association between hormone therapy and overall mortality rates in women experiencing menopause. Researchers found no evidence to support an increased risk of death among those using hormone therapy. What we have is significant as menopause can cause a range of symptoms that impact quality of life, and hormone therapy is a common treatment option.
The research provides a more nuanced understanding of the risks and benefits of hormone therapy, potentially leading to more informed decisions between patients and their doctors. While hormone therapy isn’t without potential side effects, these findings suggest that increased mortality is not a primary concern.
Further discussion with a healthcare provider is recommended to determine if hormone therapy is an appropriate treatment option, considering individual health factors and potential risks, and benefits.
